ShockWave Medical, Inc. (SWAV) Comparison with companies in other sectors?

ShockWave Medical, Inc. has a share price of 37.54M. You can analyze ShockWave Medical, Inc. (SWAV) competitors across different market sectors through stock heatmaps.

What are SWAV's NET and operating margins?

ShockWave Medical, Inc. (SWAV) operating margin is around 0.21, and net profit margin is approximately 0.24 as of the latest reports.

In what way does SWAV's earnings per share (EPS) trend reflect its financial momentum?

ShockWave Medical, Inc. (SWAV) EPS is 4.25 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for ShockWave Medical, Inc. is 78.76, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for ShockWave Medical, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for ShockWave Medical, Inc. like P/E which is 125.25, P/B which is 16.60, and PEG which is 12.25. Compare them with sector averages to evaluate if the stock is priced fairly.

ShockWave Medical, Inc.

SWAV•NASDAQ

Healthcare

Medical - Devices

$334.75

$-0.08(-0.02%)

ShockWave Medical, Inc. (SWAV) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$4.25

P/E Ratio

78.76

ROE

0.14%

Net Margin

0.24%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$12.57B

Shares OutstandingTotal number of shares issued

$37.54M

Book Value/ShareNet worth per share

$20.16

Revenue/ShareAnnual revenue per share

$11.31

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$4.25

Net MarginNet income as percentage of revenue

23.63%

Operating MarginOperating income as percentage of revenue

20.62%

ROEReturn on shareholders' equity

14.03%

ROAReturn on total assets

6.06%

ROCEReturn on capital employed

5.61%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.44

Cash/ShareCash and equivalents per share

$27.60

FCF YieldFree cash flow as percentage of market cap

0.72%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for SWAVFinancial Ratios Analysis details for SWAV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for SWAVSector Benchmarking details for SWAV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for ShockWave Medical, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of ShockWave Medical, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account ShockWave Medical, Inc.'s unique business strengths and challenges.

Key Financial Metrics for ShockWave Medical, Inc.

For ShockWave Medical, Inc., essential financial indicators include EPS 4.25, PE 78.76, and ROE 0.14. These key ratios reveal insights into ShockWave Medical, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare ShockWave Medical, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of ShockWave Medical, Inc.

Metrics like Net Margin 23.63% and ROA 6.06% shed light on how well ShockWave Medical, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether ShockWave Medical, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of ShockWave Medical, Inc.

Using ratios such as P/B Ratio 16.60 and PEG Ratio 12.25, investors can assess whether ShockWave Medical, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with ShockWave Medical, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for ShockWave Medical, Inc.

Financial health indicators, such as Debt/Equity Ratio 1.03 and Cash Flow $2.44, provide a snapshot of ShockWave Medical, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like ShockWave Medical, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for ShockWave Medical, Inc.

Investing in ShockWave Medical, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at ShockWave Medical, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;